ViCentra Strengthens Leadership Team to Accelerate Growth
ViCentra, a European medical device company, announced two strategic senior leadership appointments following the company's recent $85 million Series D financing.
New Appointments
- Karen Baxter, former VP & GM at Dexcom, joins as SVP Sales, Europe, bringing deep expertise in diabetes device commercialization across Europe.
- Jay Little, a long-time commercialization and market access executive at Medtronic Diabetes, takes on the newly created role of Vice President of Strategy & Business Development.
These appointments aim to accelerate growth and redefine insulin delivery for people with diabetes with the Kaleido insulin patch pump system.
No comment
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author summary: ViCentra appoints new leaders.
More News
- Guadeloupean artist Kelly Sinnapah Mary wins French art prize at Art Basel Miami Beach
- NBA: Spurs at Timberwolves
- How to watch Islanders vs. Lightning: TV channel and streaming options for December 6
- Hamilton urges Ferrari to make 'personnel changes' ahead of F1 2026
- Kelly Osbourne — Instagram Snapshot
- Jack Osbourne breaks silence on jungle feud with Kelly Brook
- Kelly Massol : « J’ai réalisé 40% de mon ambition »
- Spurs' Luke Kornet out Friday
- Islanders vs. Lightning (Dec 6, 2025) Pregame
- Pelicans' Questionable Offseason Trade Looks Better After Saddiq Bey's Rise